Bapcor (ASX:BAP) Is Down 58.3% After Deeply Discounted Equity Raising And Goodwill Impairment - What's Changed

• Bapcor recently reported a half‑year statutory net loss of A$104.8 million, driven largely by a goodwill impairment in its New Zealand operations, and launched a deeply discounted A$200 million equity raising through an entitlement offer and placement to shore up its balance sheet.

• The capital raising, which nearly doubles the number of shares on issue and follows temporary changes to banking covenants, marks a significant reset of Bapcor's financial and operational footing under new leadership.

• We'll now examine how this large, discounted equity raising and associated balance sheet repair reshape Bapcor's existing investment narrative and risks.

AI is about to change healthcare. These 10 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early.

Bapcor Investment Narrative Recap

To stay invested in Bapcor now, you need to believe the capital raise and turnaround plan can stabilise the core trade and wholesale business and rebuild profitability. The most important near term catalyst is execution on pricing and margin recovery, while the biggest current risk is ongoing market share loss and operational missteps. The deeply discounted equity raising is highly material here, as it both shores up the balance sheet and significantly dilutes existing holders.

The A$200 million follow on equity offering, at A$0.60 per share and nearly doubling shares on issue, is the key announcement that reshapes this story. It directly addresses concerns about leverage and covenant pressure but also crystallises the cost of past underperformance for shareholders, making future earnings delivery and cash flow quality even more critical as catalysts from here.

Yet despite the balance sheet repair, investors should be aware that...

Read the full narrative on Bapcor (it's free!)

Bapcor's narrative projects A$2.1 billion revenue and A$106.9 million earnings by 2028. This requires 2.2% yearly revenue growth and an earnings increase of about A$78.8 million from A$28.1 million today.

Uncover how Bapcor's forecasts yield a A$3.21 fair value , a 349% upside to its current price.

Exploring Other Perspectives

Before this shock loss and equity raising, the most pessimistic analysts were already assuming flat to declining revenue near A$2.0 billion and only A$99.1 million of earnings by 2028, which shows just how differently you and other investors might view risks like execution problems and restructuring costs once these latest events are fully reflected in expectations.